Abivax SA Sponsored ADR ABVX
91.06
(3.81)
(4.02%)
as of 25 Sep
- Market cap
- $8.2B
- P/E
- 0.0×
Follow ABVX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
7.86 | 8.75 | 8.25 | 5.97 |
Net Debt/EBITDA |
6.88 | 7.47 | 8.92 | 4.89 | |
Debt/Assets |
7.04% | 0.32% | 0.26% | 0.26% | |
Debt/Equity |
0.09 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.48 | 0.23 | 1.04 | 0.44 | |
Capex/Depreciation |
0.02 | (0.34) | (0.15) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.17) | (0.30) | (0.75) | (0.76) | |
Cash per Share |
9.60 | 8.76 | 7.40 | 6.00 | |
Shareholders Equity per Share |
8.19 | 7.41 | 6.37 | 5.35 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.19 | 7.41 | 6.37 | 5.35 | |
Free Cash Flow |
(85.56) | (21.21) | (59.19) | (60.19) | |
Working Capital |
631.83 | 552.38 | 527.84 | 413.85 | |
Capital Expenditures |
0.01 | (0.10) | (0.06) | (0.13) | |
Net Current Asset Value |
559.30 | 477.57 | 463.09 | 385.65 | |
| Other line items | |||||
Quick Ratio |
7.86 | 8.75 | 8.25 | 5.97 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.17) | (0.30) | (0.75) | (0.75) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
22.99 | 17.66 | 19.41 | 19.58 | |
Average Payables |
34.66 | 44.95 | 47.05 | 55.31 | |
Average Assets |
534.28 | 441.60 | 408.12 | 336.61 | |
Average Common Equity |
366.89 | 279.47 | 247.93 | 185.53 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates · fundamentals updated 23 Sep 2026